Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 3736 AL 3750

Predictors of cognitive decline and treatment response in a clinical trial on suspected prodromal Alzheimer's disease

Teipel SJ, Cavedo E, Grothe MJ, Lista S, Galluzzi S, Colliot O, Chupin M, Bakardjian H, Dormont D, Dubois B, Hampel H; Hippocampus Study Group.

Neuropharmacology. 2016 Sep;108:128-35. doi: 10.1016/j.neuropharm.2016.02.005. Epub 2016 Feb 10.

Amyloid PET Screening for Enrichment of Early-Stage Alzheimer Disease Clinical Trials: Experience in a Phase 1b Clinical Trial

Sevigny J, Suhy J, Chiao P, Chen T, Klein G, Purcell D, Oh J, Verma A, Sampat M, Barakos J.

Alzheimer Dis Assoc Disord. 2016 Jan-Mar;30(1):1-7. doi: 10.1097/WAD.0000000000000144.

Course and Determinants of Anosognosia in Alzheimer's Disease: A 12-Month Follow-up

Turró-Garriga O, Garre-Olmo J, Calvó-Perxas L, Reñé-Ramírez R, Gascón-Bayarri J, Conde-Sala JL.

J Alzheimers Dis. 2016;51(2):357-66. doi: 10.3233/JAD-150706.

Frontal Lobe Degeneration in Adults with Down Syndrome and Alzheimer's Disease: A Review

Fonseca LM, Yokomizo JE, Bottino CM, Fuentes D.

Dement Geriatr Cogn Disord. 2016;41(3-4):123-36. doi: 10.1159/000442941. Epub 2016 Feb 19.

On cognitive ecology and the environmental factors that promote Alzheimer disease: lessons from Octodon degus (Rodentia: Octodontidae)

Rivera DS, Inestrosa NC, Bozinovic F.

Biol Res. 2016 Feb 20;49:10. doi: 10.1186/s40659-016-0074-7.

Could Better Phenotyping Small Vessel Disease Provide New Insights into Alzheimer Disease and Improve Clinical Trial Outcomes?

Marnane M, Hsiung GY.

Curr Alzheimer Res. 2016;13(7):750-63. doi: 10.2174/1567205013666160222112634.

Gait dyspraxia as a clinical marker of cognitive decline in Down syndrome: A review of theory and proposed mechanisms

Anderson-Mooney AJ, Schmitt FA, Head E, Lott IT, Heilman KM.

Brain Cogn. 2016 Apr;104:48-57. doi: 10.1016/j.bandc.2016.02.007. Epub 2016 Feb 27.

Optimal nonpharmacological management of agitation in Alzheimer's disease: challenges and solutions

Millán-Calenti JC, Lorenzo-López L, Alonso-Búa B, de Labra C, González-Abraldes I, Maseda A.

Clin Interv Aging. 2016 Feb 22;11:175-84. doi: 10.2147/CIA.S69484. eCollection 2016.

Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit

Molinuevo JL, Cami J, Carné X, Carrillo MC, Georges J, Isaac MB, Khachaturian Z, Kim SY, Morris JC, Pasquier F, Ritchie C, Sperling R, Karlawish J.

Alzheimers Dement. 2016 May;12(5):614-22. doi: 10.1016/j.jalz.2016.01.009. Epub 2016 Mar 15.

Dogs with Cognitive Dysfunction as a Spontaneous Model for Early Alzheimer's Disease: A Translational Study of Neuropathological and Inflammatory Markers

Schütt T, Helboe L, Pedersen LØ, Waldemar G, Berendt M, Pedersen JT.

J Alzheimers Dis. 2016 Mar 15;52(2):433-49. doi: 10.3233/JAD-151085.

Effects of Citalopram on Neuropsychiatric Symptoms in Alzheimer's Dementia: Evidence From the CitAD Study

Leonpacher AK, Peters ME, Drye LT, Makino KM, Newell JA, Devanand DP, Frangakis C, Munro CA, Mintzer JE, Pollock BG, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG, Porsteinsson AP; CitAD Research Group.

Am J Psychiatry. 2016 May 1;173(5):473-80. doi: 10.1176/appi.ajp.2016.15020248. Epub 2016 Apr 1.

Alzheimer's Disease Genetic Risk Factor APOE-ε4 Also Affects Normal Brain Function

Di Battista AM, Heinsinger NM, Rebeck GW.

Curr Alzheimer Res. 2016;13(11):1200-1207. doi: 10.2174/1567205013666160401115127.

Poor self-rated health did not increase risk of permanent nursing placement or mortality in people with mild Alzheimer's disease

Nielsen AB, Siersma V, Waldemar G, Waldorff FB.

BMC Geriatr. 2016 Apr 19;16:87. doi: 10.1186/s12877-016-0262-x.

My Mind Project: the effects of cognitive training for elderly-the study protocol of a prospective randomized intervention study

Giuli C, Fattoretti P, Gagliardi C, Mocchegiani E, Venarucci D, Balietti M, Casoli T, Costarelli L, Giacconi R, Malavolta M, Papa R, Lattanzio F, Postacchini D.

Aging Clin Exp Res. 2017 Jun;29(3):353-360. doi: 10.1007/s40520-016-0570-1. Epub 2016 Apr 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias